Related Experiment Videos
Vascular stiffness: measurements, mechanisms and implications
1Berlex Biosciences, 2600 Hilltop Drive Richmond, CA 94804, USA. jim_wang@berlex.com
Current Vascular Pharmacology
|August 24, 2004
Summary
Vascular stiffness increases with aging and cardiovascular disease risk factors. Monitoring pulse wave velocity in mouse models can help understand and potentially treat vascular stiffening.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Aging Research
Background:
- Aging is the primary driver of vascular stiffness.
- Cardiovascular disease risk factors like smoking, hypertension, and diabetes alter vascular properties.
- Increased vascular stiffness elevates heart afterload stress.
Purpose of the Study:
- To review the evidence linking atherosclerosis, endothelial nitric oxide, angiotensin II, and estrogen to vascular stiffness.
- To discuss the influence of hemodynamic, metabolic, and inflammatory stimuli on arterial integrity.
- To explore potential mechanisms modulating vascular stiffness.
Main Methods:
- Utilizing pulse wave velocity (PWV) as an index for vascular stiffness.
- Reviewing data from laboratory animal models, particularly mouse models.
- Considering both invasive and noninvasive methods for measuring PWV in rodents.
Main Results:
- Atherosclerosis significantly contributes to vascular stiffening.
- Endothelial nitric oxide plays a crucial role in regulating vascular stiffness.
- Angiotensin II exacerbates vascular injury and stiffness, while estrogen treatment reduces inflammation and stiffness.
Conclusions:
- Understanding the factors influencing vascular stiffness is key for disease prevention.
- Mouse models provide valuable insights into vascular stiffening mechanisms.
- Targeting pathways involving nitric oxide, angiotensin II, and estrogen may offer therapeutic strategies.